Understand · Discuss · Plan together
Understanding Genetic Test Results
The same word “negative” can mean different things in different families.
Chapter 9 of 16
Explore all 16 chapters
Five laboratory categories
ACMG/AMP terminology distinguishes pathogenic, likely pathogenic, uncertain significance, likely benign and benign. Pathogenic and likely pathogenic findings may guide care when they fit the gene, inheritance and clinical context. Benign findings are not treated as cancer-predisposing variants.
Four common conversations
| Result | Meaning | Practical next step |
|---|---|---|
| Positive: pathogenic / likely pathogenic | An actionable inherited susceptibility may be identified; this does not diagnose cancer. | Confirm the relevant syndrome and obtain an individual plan. |
| True negative | The known pathogenic family variant was specifically tested and not found. | The risk from that variant is removed; other personal or family risks may remain. |
| Uninformative negative | No causative variant was found, but no familial cause was established. | Continue assessment and screening based on history; ask whether the test has important limitations. |
| VUS | Evidence cannot yet say whether the change is harmful. | Do not use the VUS to choose preventive surgery or predictive cascade testing. Base care on established risk factors. |
A VUS is not “almost positive”
The classification may change as evidence accumulates. Keep contact details current and ask the laboratory or genetics service how updates are communicated. Testing relatives occasionally helps a specialist resolve a variant, but this is different from routine predictive testing for an established harmful variant.
Check the complete report
Keep the gene, exact variant notation, classification, sample type, laboratory, date and test limitations together. A screenshot saying “mutation detected” can omit crucial context. If laboratories disagree, seek expert reconciliation before an irreversible decision.
Why a negative result needs context
Tests differ in their coverage, and scientific knowledge evolves. A normal result does not cancel symptoms, routine screening or a strong family history. Ask which unanswered question would justify future reassessment rather than ordering repeated panels without a purpose.
Sources and further reading
- ACMG/AMP — Standards for interpretation of sequence variants (2015)
- NCI — Genetic Testing for Inherited Cancer Risk
Accessible sources checked: 19 October 2026. International recommendations are identified where used; care in India requires individual clinical assessment. No claim is made to have directly verified restricted NCCN guidance.